|
|
The Editorial Staff who decide to use of this option will receive the SJIF Value within 7 days.
Register journal - (Free Service)
in a scored and prestigious database of scientific journals.
Manage journal - (Free Service)
This section allows you to place information about the journal, editors, and publisher, etc.
Full list of journals from database of SJIFactor.com. It contains currently over 24000 journals from all over the world.
A proof of being indexed in SJIF Journal Rank List.
|
|
Journal of Cancer Research & Therapy
|
SJIF 2024:
Under evaluation
Area: Multidisciplinary
Evaluated version: online
|
Previous evaluation SJIF
2023: Not indexed
2022: 5.992
2021: 5.978
2020: 5.973
|
|
The journal is indexed in:
|
|
SJIFactor.com
|
|
Basic information
|
|
|
Main title
|
Journal of Cancer Research & Therapy
|
|
Other title [English]
|
Journal of Cancer Research & Therapy
|
|
Abbreviated title
|
JCRT
|
|
ISSN
|
2052-4994 (E) / 2052-4994 (P) |
|
URL
|
http://nobleresearch.org/Journal/1
|
|
Country
|
 United Kingdom
|
|
Frequency
|
Monthly |
|
License
|
Free for non-commercial use
|
|
Texts availability
|
Free
|
|
Contact Details
|
|
|
Editor-in-chief
|
Dr Richard J. Ablin
|
|
|
Department of Pathology, University of Arizona College of Medicine, Member-Arizona Cancer Center, Member- BIO5 Institute, Tucson
|
|
|
 USA
|
|
Publisher
|
NobleResearch Publishers
|
|
|
Flat No 1, 475-Palatine Road, Northenden, Manchester, P.O: M22 4DA, United Kingdom.
|
|
Journal's description
|
|
|
Journal of Cancer Research & Therapy (JCRT) is an international refereed journal, which publishes high-quality original articles reporting new information on basic and clinical aspects of cancer research and therapy. The wide range of topics includes cancer etiology and epidemiology, cancer prevention, mechanisms, molecular biology, recent developments in tumor therapy, radiation oncology, oncogenes, apoptosis, angiogenesis, metastasis, cancer image and interventional diagnosis and therapy, tumor markers, surgical oncology, chemotherapy, radiotherapy and biotherapy. The journal encourages submission of manuscripts with relevance to (but not limited to) cancer genetics, cancer pathology, cancer cytology, cancer endocrinology, clinical aspects of breast cancer, Lung cancer, genitourinary cancer, gynecologic cancer, ovarian cancer, prostate cancer, bone cancer, colorectal cancer.
|
|
|
